ArticleJournal of thoracic disease2026
Chronic thromboembolic pulmonary hypertension: insights from the 100 most cited papers: a bibliometric perspective.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a multifaceted and progressive condition that has experienced substantial advancements in research. This study undertook a bibliometric analysis of the 100 most frequently cited articles pertaining to CTEPH to delineate the most influential contributions within the field. The objective was to elucidate significant research trends, identify critical areas of focus, and inform future research trajectories. Methods: Relevant literature was selected from the Web of Science core collection. The analysis utilized a combination of advanced bibliometric tools: Microsoft Excel 2019, VOSviewer 1.6.20, CiteSpace 6.3.R1, and R 4.3.3. Results: The publication timeframe extends from 1973 to 2021, during which a peak citation count of 28,460 was recorded. Germany and the USA emerge as the predominant contributors to the body of published articles. Assistance Publique Hopitaux Paris (APHP) emerged as the leading institution, with a total of 30 publications. This was closely followed by the University of California San Diego and the University of California System, each with 28 articles. These articles were disseminated across 38 distinct journals, with the European Respiratory Journal leading in publication volume. Simonneau, Gerald is identified as the most prolific first author, contributing 12 articles. Keyword analysis reveals that early research on CTEPH primarily focused on foundational concepts and established clinical practices, as evidenced by terms such as "pulmonary thromboendarterectomy" and "management". Recently, there has been a notable and sustained shift towards advanced diagnostic methodologies, with "computed tomography" emerging as a focal point of research. Conclusions: CTEPH research has demonstrated rapid growth and increasing international collaboration over the past two decades, with evolving priorities from surgical management to holistic, patient-centered, and precision medicine approaches. These findings provide a roadmap for future research directions, emphasizing the need for early detection, individualized therapies, and continued innovation in both diagnostics and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.